Intracellular pharmacodynamics in leukemia therapy

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study.

Leukemia·2017

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.

Leukemia·2016

Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia.

Leukemia·2016

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.

Leukemia·2014

Management of older or unfit patients with acute myeloid leukemia.

Leukemia·2014

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[DDX41-mutated myeloid neoplasms].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Recent advances and future perspectives in the treatment of NK/T-cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Copper-Doped Prussian Blue Nanozymes With Hyaluronic Acid-Mediated Targeting Alleviate Oxidative Stress and Regulate Cholesterol Handling for Atherosclerosis Therapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Oncofertility in Gastrointestinal (GI) Oncology - A Pan-European study of the patient perspective.

The oncologist·2026

BRCA2-deficient endothelium: a hidden catalyst in angiotensin II-induced vascular injury.

Journal of hypertension·2026

The enigma of associations between reproductive health and development of osteoarthritis in midlife: a life-course approach.

Climacteric : the journal of the International Menopause Society·2026

AI-Based Computational Model Integrating Routinely Acquired Blood Parameters for Triage and Early Detection of Acute Myeloid Leukemia.

Biomedical engineering and computational biology·2026

Impact of cryopreservation on PBMC-derived CAR-T cell manufacturing outcomes: a systematic review.

Frontiers in immunology·2026

Related Experiment Videos

Intracellular pharmacodynamics in leukemia therapy

Related Concept Videos

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study.

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.

Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia.

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.

Management of older or unfit patients with acute myeloid leukemia.

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[DDX41-mutated myeloid neoplasms].

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

[Recent advances and future perspectives in the treatment of NK/T-cell lymphoma].

Copper-Doped Prussian Blue Nanozymes With Hyaluronic Acid-Mediated Targeting Alleviate Oxidative Stress and Regulate Cholesterol Handling for Atherosclerosis Therapy.

Oncofertility in Gastrointestinal (GI) Oncology - A Pan-European study of the patient perspective.

BRCA2-deficient endothelium: a hidden catalyst in angiotensin II-induced vascular injury.

The enigma of associations between reproductive health and development of osteoarthritis in midlife: a life-course approach.

AI-Based Computational Model Integrating Routinely Acquired Blood Parameters for Triage and Early Detection of Acute Myeloid Leukemia.

Impact of cryopreservation on PBMC-derived CAR-T cell manufacturing outcomes: a systematic review.

Related Experiment Videos

Intracellular pharmacodynamics in leukemia therapy

Related Concept Videos

Related Articles